Intratumoural heterogeneity is known to contribute to poor therapeutic response. Variations in oxygen tension in particular have been correlated with changes in radiation response in vitro and at the clinical scale with overall survival. Heterogeneity at the microscopic scale in tumour blood vessel architecture has been described, and is one source of the underlying variations in oxygen tension. We endeavour to determine whether histologic scale measures of the erratic distribution of blood vessels within a tumour can be used to predict differing radiation response. Using a two-dimensional hybrid cellular automaton model of tumour growth, we evaluate the effect of vessel distribution on cell survival outcomes of simulated radiation therapy. Using the standard equations for the oxygen enhancement ratio for cell survival probability under differing oxygen tensions, we calculate average radiation effect over a range of different vessel densities and organisations. We go on to quantify the vessel distribution heterogeneity and measure spatial organization using Ripley's L function, a measure designed to detect deviations from spatial homogeneity. We find that under differing regimes of vessel density the correlation coefficient between the measure of spatial organization and radiation effect changes sign. This provides not only a useful way to understand the differences seen in radiation effect for tissues based on vessel architecture, but also an alternate explanation for the vessel normalization hypothesis.
Introduction
It is increasingly recognised that an important aspect of cancers is their 2 heterogeneity [1] . This heterogeneity exists between patients, between different 3 tumours within a single patient [2] , within the differing cellular populations in a single 4 tumour and even at the genetic scale between cancer cells originating from the same 5 ancestor [3] . In particular, microenvironmental heterogeneity is becoming widely 6 accepted as a key factor in tumour progression and response to therapy [1] . Nutrients, 7 growth factors, extracellular matrix and other cell types are all part of the normal tissue 8 that surrounds and pervades a solid tumour and has been shown to vary widely across 9 different tumour stages and types. This is, in part, due to the dynamic and 10 heterogeneous interplay between the tumour and its microenvironment. 11 Radiation biologists have, for many years, understood the importance of cell 12 biological and microenvironmental factors on radiation response. Current radiation 13 therapy dose planning, however, largely neglects this information and is, instead, based 14 on years of clinical experience using intuition and trial and error. As such, there remains 15 limited tailoring of dose planning to an individual patient's tumour. With the advent of 16 modern quantitative histologic [4] and biological imaging methods [5] , however, this 17 paradigm is poised to change. 18 Research in this area over the last decade [6] has sought to understand the 19 macroscopic spatial distribution of hypoxia within tumours using non-invasive imaging. 20 This information has then been utilised to develop spatially heterogeneous dose plans 21 to improve tumour control. For example, Malinen et al. [7] inferred average oxygen 22 concentrations from radiocontrast concentrations measured by Dynamic Contrast 23 Enhanced (DCE) Magnetic Resonance Imaging (MRI) in a dog sarcoma. Other work to 24 understand the effects of radiation in individual patients has utilized MRI scans in 25 combination with mathematical models of tumour growth. These models have 26 incorporated heterogeneity in cell type by considering a two compartment spatial partial 27 differential equation (PDE) model, separately considering proliferation and motility, 28 without consideration of oxygen effects [8] to explain different radiation responses 29 measured by changes in tumour size over time. More recently, cellular automaton 30 models of stem cell driven tumours, comprised of populations with differences in 31 proliferative phenotype [9] were used to compare tumour response to a range of 32 spatially heterogeneous radiation dose plans or to different orders of radio-and 33 chemo-therapeutic strategies [10] . What is lacking to date, however, is research into 34 how tissue level microenvironmental heterogeneity can affect radiation response, and 35 
PLOS
2/30 how this could be inferred from patient data. 36 Heterogeneity in tumour oxygenation, in particular the occurrence of hypoxia, is a 37 well-known cause of radiation therapy failure [11, 12] . Work done in vitro to understand 38 differences in radiation effect due to oxygenation differences have been valuable, and 39 have established an empiric relationship called the Oxygen Enhancement Ratio 40 (OER) [13] to understand how radiation efficacy varies with oxygen concentration. 41 These studies do not, however, allow us to understand the effects of radiation in vivo, as 42 they do not consider the heterogeneity of oxygenation at the microscopic, cellular scale. 43 Beyond the macroscopic changes in oxygenation, vessel and cellular density and 44 metabolism, a number of theoretical studies have suggested that the local microscopic 45 heterogeneity in oxygenation can vary widely in space and time in tumours [14, 15, 16] 46 and healthy tissues [17] alike. In addition a large body of work has sought to 47 understand an apparent paradox of therapy directed at angiogenesis, the process of 48 new vessel creation [18] . In short, it was thought that by blocking a cancer's ability to 49 create new vessels, it would be possible to starve the cancer of nutrients and oxygen, 50 quickly leading to its demise. While effective anti-angiogenesis drugs have been 51 developed, this promise never came to fruition. The leading hypothesis to explain this 52 failure is termed the 'vascular normalization hypothesis' [19] , which suggests that these 53 drugs, which block vascular endothelial growth factor (VEGF), do not simply inhibit new 54 vessel production, but instead work by normalizing the vascular bed in question by 55 pruning out ineffective vessels. This hypothesis, while well supported by experimental 56 work, has not yet been able to fully explain results at the clinical scale [20] . These 57 studies highlight an opportunity to improve our understanding of how spatio-temporal 58 oxygen dynamics at the cellular scale affect tissue-level response to therapy. To this 59 end, we develop a computational, hybrid cellular automaton model of a tumour growing 60 within a surrounding normal tissue in a vascularized domain which we use to investigate 61 whether spatial statistics gleaned from measures of vascular organisation can be used 62 to predict radiation efficacy. By identifying broad relationships between in silico tissue 63 architecture and radiation response, we aim to progress toward a translatable method 64 of radiation plan optimization using information extracted from biopsies. 65 The remainder of this paper is structured as follows. We first elucidate our methods 66 by describing the underlying rules and parameters governing the cellular automaton as 67 well as the method of calculating oxygen transport and uptake. In the results section we 68 describe simulation results concerning healthy tissue growth in regularly arranged and 69 then heterogeneous vascular architectures. We then describe tumour growth and 70 invasion in regular architectures and follow this with observations concerning the 71 distribution of oxygen tension in different possible vascular organisations. We then 72 develop a metric, based on Ripley's L function [21] , which allows us to quantify and 73 correlate these patterns with radiation response. We end with a discussion of how this 74 metric reconciles some of the difficulties with the vascular normalisation hypothesis, 75 and suggest how the metric might be used in the clinic to personalise radiation dose 76 planning.
77

Methods
78
We consider the effect of a heterogeneous microenvironment through the inclusion of 79 en face blood vessels modeled as point sources of oxygen, and through competition of 80 tumour cells with an initial field of healthy cells. We begin by creating a hybrid cellular 81 automaton (HCA) model [22] in which we describe cells by individual agents whose for these cell fate decisions are listed in Table 1 and Fig. 1 , respectively, and will be 106 discussed individually in the coming sections.
107
Oxygen consumption and transport. With the advent of single-cell techniques for 108 measuring oxygen consumption rates, quantitative data concerning the differential 109 oxygen consumption rates of different types of cancer cells are now available. It is 110 widely accepted that, in general, cancer cells are more metabolically active than healthy 111 cells because of the Warburg shift [23] or other metabolic abnormalities, and we thus 112 use a modification of normal consumption. 113 The continuous component of our model describes the distribution and consumption 114 of nutrients. While it is clear that many nutrients are of biological importance, in this 115 model we focus on oxygen as it is central to the DNA-damaging effects of photon 116 radiation therapy [24] . Blood vessels, which are each modeled as point sources of 117 oxygen, occupying one lattice site, are placed randomly throughout the lattice at the 118 start of a given simulation, at a specified spatial density Θ. While in reality, vessels can 119 be different sizes, they tend to be normally distributed around a mean size, and a 120 variety of metrics including number of vessels, total vessel area and vascular fraction 121 have been used interchangeably [25, 26] . As we are interested in the dynamics over 122 the time scale of radiation treatment (order days), in all simulations we neglect vascular 123 remodeling and angiogenesis, processes which are triggered by hypoxia and mediated 124 by hypoxia inducible factor-1α (HIF-1α) and VEGF, among other molecules, and have 125 been well studied [27, 28] . Each vessel is assumed to carry an amount of oxygen equal 126 to that carried in the arterial blood [29] . This oxygen is then assumed to diffuse into the 127 surrounding tissue and be consumed by normal and tumour cells. 128 The spatiotemporal evolution of the oxygen field is described by the
coefficient of oxygen, which for simplicity we assume to be constant, corresponding to 135 linear, isotropic diffusion. The function f c (x, t) denotes the cellular uptake of oxygen, 136 whose form is given by 
where r c and K m denote the maximal uptake rate and effective Michaelis-Menten 142 constant, respectively. We supplement equation (1) with the following initial and 143 boundary conditions. We begin with a spatially uniform oxygen distribution c(x, 0) = c 0 , 144 a positive constant, with the entire domain, (0, N∆x) 2 \V , occupied by normal cells. To 145 simulate carcinogenesis, we replace the cell in the central lattice site with a tumour cell. 146 Vessels are placed throughout the domain at a prescribed density and pattern, 147 depending on the situation being simulated. To approximate the constant value of the 148 oxygen concentration in the arterial blood we impose c(x, t) = c max at each point, x ∈ V , 149 where there is a vessel. We further impose no-flux boundary conditions at the edge of 150 the domain, 151 n · ∇c = 0,
where n is the unit normal outward vector to the domain boundary.
152
Proliferation. Cell proliferation is governed by a complicated set of subcellular 153 processes, and has been modelled in great detail [30, 31] . The cell cycle has many 154 levels of complexity including checkpoints, specific temporal sequences and many 155 biophysical processes that alter the cell shape and response to microenvironmental 156 cues and stresses at different times in the cycle [32] . As we are interested in a 157 phenomenon occurring at the much larger, tissue, scale, we will encapsulate this 158 complexity into a simple rule set and threshold values on microenvironmental (oxygen) 159 conditions and neighbourhood occupation. 160 For cells to progress through the cell cycle and divide, we require their local oxygen 161 concentration to exceed a fixed threshold value c p , and that the neighbourhood (in this 162 case utilizing a Moore neighbourhood) contains at least one empty space. If these 163 constraints are met, then we allow the cell to divide with type-specific probability p j 164 (where j ∈ {H, T }) at each automaton time step, and place the resultant daughter in a 165 randomly chosen empty neighbouring space. If no empty neighbouring space exists, 166 then the cell becomes quiescent (see below). In the case of cancer cells, we relax this 167 requirement to allow proliferation into healthy tissue, that is that normal cells are 168 considered empty spaces when assaying for empty space for division.
169
Cell death. The main mechanisms of cancer cell death considered in this study occur 170 due to severe hypoxia and radiation therapy. Healthy cells can also die through if they 171 are selected for replacement by dividing cancer cells, a situation which would normally 172 PLOS 5/30 be ascribed to a cancer cell's greater fitness, allowing it to out-compete healthy cells for 173 space or nutrients locally, or possibly secondary to an acid-mediated event [23, 33] . 174 Cells under extreme hypoxic conditions are often found to undergo autophagy 175 (directly translated as 'self-eating'), a state in which they become resistant to nutrient 176 starvation [34] , and cells are known to die over different time scales and by different 177 mechanisms (apoptosis versus necrosis) depending on the magnitude and duration of 178 the hypoxic insult. While these differences have been shown to affect tumour 179 growth [35] , as this is not the main focus of this model, we will simplify this scenario by 180 assigning a rate, 
where α and β are radiobiologic parameters associated phenomenologically with cell 186 kill resulting from 'single hit' events (α) and 'double hit' events (β) respectively, and n 187 represents the number of doses of d Gy of radiation.This metric, while originally derived 188 to fit in vitro data [36] , has since been widely used to also describe the clinical efficacy 189 of radiation [37, 38] . 190 The basic interaction driving DNA damage from radiation is mediated either by free 191 electrons or by free radicals formed by the interaction of photons with water. The DNA 192 damage instantiated by these mechanisms can be repaired by reduction by locally 193 available biomolecules containing sulfhydryl groups [24] . This damage can be made 194 more permanent, however, by the presence of molecular oxygen, which binds with the 195 DNA radical, forming a 'non-restorable' organic peroxide. This damage 'fixation' by 196 oxygen creates a situation in which the damage now requires enzymatic repair, which 197 occurs on a much longer timescale [24] . Regardless of the mechanism of radiation 198 sensitisation by oxygen, the effect is well documented, and has been modelled by 199 replacing the parameters α and β in equation (5) with functions of the oxygen 200 concentration using the oxygen enhancement ratio (OER):
where α max and β max are the values of α and β under fully physiologically oxygenated 202 conditions and α(c), β(c) are, respectively, the values of α, β at oxygen concentration c. 203 We define the OER as a function of the oxygen concentration by using the empirically 204 established relation [13, 39] 205
which is solved individually for α and β (see Table 1 for parameters).
206
Quiescence. In response to a lack of oxygen or other nutrients or external 207 mechanical cues indicating overcrowding, cells enter a temporary state of quiescence 208 during which no division occurs [40] . We model this process through an oxygen
below which cellular division is not possible and by the spatial constraint that the cell is 211 quiescent if there are no empty neighbouring lattice sites (using a Moore 212 neighbourhood). In the case of a cancer cell, we require that at least one space be 213 empty or inhabited by a normal cell, a situation in which we assume that the cancer cell 214 will replace the normal cell if chosen for division. When the conditions for quiescense 215 are no longer present, the cell's state of quiescence is reversed. 216 
PLOS 6/30
Normal tissue approximation. The invasion of cancer cells into healthy tissue has 217 been modelled extensively [41, 42, 43, 44] . While this process is not the focus of our 218 study, we nevertheless must consider the healthy tissue surrounding our growing 219 tumour, as it plays an important role in modulating the local oxygen concentration. 220 Previous investigations have modelled tumour spheroid growth [45] , or assumed a 221 constant influx of oxygen from the boundary of the tissue, but as we endeavour to 222 understand how heterogeneous vascularisation affects the growth of a tumour, we must 223 also incorporate normal tissue effects [14] . To do this, we assume that the entire tissue 224 is initially comprised of normal cells, which can divide if they have sufficient space, 225 which consume oxygen at a rate of µ H r (c) and are subject to hypoxic cell death. In 226 addition, normal cells can die through competition with cancer cells.
227
Cell competition. The ability to invade into normal tissue is one of the 'Hallmarks of 228 Cancer' [46] . Several mechanisms for this have been proposed and modelled, including 229 degradation of extracellular matrix by secreted proteases [41, 47] and mediated by 230 excreted lactic acid [42, 43] . As this specific interaction is not our focus, we make the 231 simplifying assumption that normal cells do not spatially inhibit cancer cell proliferation, 232 and a cancer cell can freely proliferate and place a daughter onto a lattice location 233 where a normal cell is located, causing the normal cell to die, either through an 234 acid-mediated or simple fitness based competition mechanism [48] . Normal cells, 235 however, are spatially inhibited by cancer cells and other normal cells.
236
Vascular dynamics. While in healthy tissue vessels are normally patent, as tumours 237 grow the vasculature can experience significant spatio-temporal changes. There 238 continues to be significant theoretical work to describe angiogenesis, the process of 239 new vessel formation [22, 27] , as well as the biophysical processes governing vascular 240 occlusion [49, 50] . In this study, we seek only to understand the effect of 241 heterogeneous oxygen concentrations on tumour growth and progression [14] . 242 Therefore, we consider only the simplest scenario, in which there is no feedback from 243 the environment to the vessels.
244
Coupling models in the hybrid cellular automaton 245 Having described each of the constituent parts of the model, we now describe how they 246 are coupled to form the HCA. We consider a two-dimensional lattice of size N × N, with 247 each lattice element identified by coordinates (i∆x, j∆x) where i, j ∈ {1, 2, ... , N}.
248
As schematised in Fig. 1 , at each automaton time step every cell (chosen in random 249 order) in the domain is subject to a series of decisions based on the current automaton 250 state and local oxygen concentration, c(x, t). The specific checks that each cell 251 undergoes, regardless of its phenotype, are: Cell-microenvironment interaction. As we endeavour to understand the effects of a 260 heterogeneous oxygen distribution on healthy tissues and tumours, we must consider a 261 number of parameters that govern a cell's behaviour in response to these 262 environmental cues. Specifically, we consider the hypoxia threshold, c ap , below which 263 cells will die, and be removed from the system. As cell fate decisions are made on a 264 much slower time scale than oxygen diffusion, there is a potential for update bias which 265 would entail cell fate decisions made long after the conditions for these decisions were 266 met. To reduce this, we will ascribe a probability per automaton update, p d , to this death 267 and removal, and update the HCA more frequently than the cell cycle time. We further 268 consider a baseline oxygen consumption required for cellular processes, r c , and a 269 threshold for cells to be proliferatively active, c p [51] .
270
Non-dimensionalisation and parameter estimation. In order to place the model in 271 an appropriate spatial and temporal scale, we non-dimensionalise the system. We 272 rescale time by a typical cell cycle time, τ = 16h [52] , and lengths by a typical diameter 273 ∆x = 50µm for a glioma cell [53] . We choose to rescale the oxygen concentration to 274 reflect the average oxygen concentration in the arterial blood, estimated at about 275 80mmHg (5.14 × 10 −13 mol −1 cell −1 ) [54] , so that the non-dimensional oxygen 276 concentration at a vessel takes the value 1. 
where f c k i,j is the cell-specific oxygen consumption rate defined in equation (2). 289 Rearranging equation (9) to obtain a solution for c k+1 i,j gives 290
At each oxygen time step, the oxygen concentration in a given lattice site is updated 291 using equation 10. To impose the zero-flux boundary conditions we modify equation 292 (10) in the cases where i, j ∈ {1, N}. For example, to calculate the oxygen 293 concentration experienced by a cell at the left-hand boundary (i.e. i = 1) from outside 294 the domain (i.e. i = 0) we discretize the no-flux boundary condition to obtain c k 0,j = c k 2,j , 295 which we substitute into equation (10) . Note that lattice sites occupied by vessels have 296 fixed oxygen values (1 in the non-dimensional system), so we do not update them.
297
Tumour control probability. The tumour control probability (TCP) is a measure that 298 approximates the probability of eradicating all cells within a tumour and thereby 299 controlling (in this case 'curing') it. While a number of methods, both deterministic and 300 stochastic, have been proposed to define such a measure [60] , the most commonly 301 used formulation assumes that the number of surviving cells capable of proliferation 302 after radiation follows Poisson statistics and that the TCP is calculated by
where N 0 is the number of cells in the tissue before radiation therapy and SF is the 304 surviving fraction defined by (5) . 305 To compare the effect of radiation on different populations of cells in our model, we 306 calculate the total number of cells surviving a given therapeutic intervention. To this 307 end, we consider the individual survival probability of cells experiencing a given oxygen 308 concentration. Let N k i be the number of cells in the tissue that experience a oxygen 309 concentration in the interval [i∆c, (i + 1)∆c) at time t k = k ∆t, for i ∈ {0, ... , M}. Here we 310 define ∆c = 0.01, and M∆c = 1, reflecting the fact that the oxygen concentration is 311 bounded by its non-dimensional value in the arterial blood, which is 1. We assume that 312 radiation effect is instantaneous, and represent the time after radiation as t k+1 . The 313 number of cells experiencing an oxygen concentration in the interval [i∆c, (i + 1)∆c) 314 immediately following a single radiation dose d is given by
Thus the total number of surviving cells at time t k+1 is given by
To calculate the number of surviving cells in a given domain after simulated radiation, 317 we first calculate the individual values of α i and β i for each interval of oxygen 318 concentration using equations (6) - (7) . We can then compute the surviving fraction 319 after a simulated single 2Gy dose of radiation (d = 2Gy, n = 1) by utilising equations 320 (12) and (13) and assuming initial distribution of cellular-oxygen given by the 321 simulations represented in Fig. 5 .
322
Results
323
Oxygenation of healthy tissue 324 Regular vascular patterning preserves oxygen distribution shape but not mean. 325 We As expected, the closer the vascular packing in the domain, the more cells can be 336 PLOS 11/30 supported and the higher the mean oxygen tension (Fig. 2 ). There is a critical value for 337 vessel density below which cells begin to die, and therefore the proportion of the 338 domain inhabited by cells (termed carrying capacity henceforth) drops below unity. This 339 value is between 2.7 × 10 −3 vessels per lattice site and 3.1 × 10 −3 vessels per lattice 340 site for the parameters modeled (Table 1) , which is well within an order of magnitude to 341 the vascular area to tumour area ratio reported by Zhang et al. [63] . 342 In addition to the carrying capacity, we investigate the distribution of cellular-oxygen 343 concentration. This distribution provides a non-spatial summary statistic of an otherwise 344 spatial entity: we can understand how many (or what proportion) of cells within the 345 domain exist at certain oxygen concentrations, a measure which will become important 346 later when we consider the effect of radiation. In Fig. 2 we note that, while the mean 347 cellular oxygen concentration (mean of the cell-oxygen distribution) varies considerably 348 (from a non-dimensional value of 0.16 to 0.45), the second and third moments of the 349 distribution vary little, with the standard deviation staying between 0.08 − 0.11 and the 350 skewness between 3.18 − 3.3. That is, the distribution of cellular oxygen concentration 351 maintains its variance about its mean as well as its level of symmetry while the vascular 352 patterning is regular.
353
Irregular vascular patterning results in variation in oxygen distribution shape. 354 We next explore how the oxygen concentration that the population of healthy tissue 355 supported experiences based on changes in density and patterning of vessels in 356 irregularly vascularized domains. While this is a situation that would not likely be seen 357 in the healthy state, understanding the behaviour of the model in this simple situation is 358 valuable before progressing to more complex states. To this end we simulate the 359 resulting healthy tissue growth and maintenance in a variety of randomly generated 360 vascular patterns of the same density (Fig. 3) . We plot the final, stable distribution of 361 healthy cells for a random placement of vessels for a given density (Θ = 0.001, top; 362 Θ = 0.0025, middle; and Θ = 0.004, bottom) in the left and middle columns. In the right 363 column, we plot the average distribution of cells at specific oxygen concentrations over 364 ten simulations with different vascular patterns. 365 As expected, we see an increase in carrying capacity with increasing vascular 366 density, similar to the regularly vascularized scenario, with mean cellularity (cells / 367 domain size) increasing from 0.3445 to 0.9424, with standard deviations from 0.0208 to 368 0.0312. Over ten simulations in the irregularly vascularised cases, however, we find 369 striking differences in the distribution of cell-specific oxygen concentration ( Fig. 3, right) . 370 While in the regular case ( Fig. 2) we find conserved cellular-oxygen distribution shapes 371 (second and third moments), in the irregularly vascularized case we find two changes. 372 First, even in the highest vessel density case there is a large peak at c ap and second, 373 the distribution becomes more and more skewed (to the left) as the vessel density 374 decreases (skewness ranging from 0.2878 − 1.895). the centre of the computational domain with the initial cancer cell as in certain regular 386 spacing patterns, the centre would be an area of necrosis and the simulation would end 387 with no cancer cells. 388 We plot the results of these simulations in Fig. 4 along with the individual simulation 389 growth rates. We find four qualitatively different patterns/rates of growth for different 390 vascular densities. First, when there is high vessel density (box 1, green trace, Fig. 4 ), 391 the tumour undergoes rapid growth. This approximates contact inhibited tumour growth 392 with proliferation at the edge only. Even in this growth regime, we begin to see necrotic 393 areas in the bulk of the tumour (box 2, blue trace, Fig. 4 ). The second qualitatively 394 different regime is when the vessel density decreases to Θ = 0.0033, and the spacing 395 of the vasculature is such that it has lost its ability to maintain continuous populations of 396 cancer cells (box 3, red trace, Fig. 4 ). In this regime, we find that the cancer's growth 397 rate begins to slow, and further, that the boundary begins to become irregularly shaped 398 as the cancer cells have to persist in regions of hypoxia long enough to place daughters 399 in the new, adjacent, areas of increased oxygen, an event that occurs stochastically. the healthy tissue and a sharp reduction in tumour growth rate (box 4, cyan trace, 402 Fig. 4 ). The final scenario is defined by tissue that is so poorly vascularized that the 403 healthy tissue cannot maintain contiguous populations, and the cancer cannot continue 404 growing beyond the area of initial vessel oxygenation (box 5, black trace, Fig. 4 ), and 405 would need to produce its own vessels to grow further.
375
Vascularised tumour growth and invasion
406
Tissue carrying capacity and vessel density. We next investigate in further detail 407 the effect of vessel density on the carrying capacity and cellular-oxygen distribution. We 408 consider a domain of size N = 73 (chosen for ease of comparison for normal vessel 409 spacing) and vary vessel number from very low until we reach saturation of cells (in this 410 case from 3 to 236 vessels). In each simulation, we initialize the domain full of cancer 411 cells and then allow the tissue to experience oxygen dependent birth and death until a 412 dynamic equilibrium is reached, defined as experiencing less than a 1% change in cell 413 number for 50 time steps. We choose this initial condition, instead of seeding the 414 domain with a single cell, because, in this section, we are not interested in growth 415 kinetics, but instead focus on tumour bulk equilibrium characteristics. From this point, 416 we then record and average 100 time steps of cell and oxygen concentration data. For 417 each vessel number, we run 500 simulations, as detailed above, with random vessel As expected, we see a monotonic approach to cellular saturation as vessel number 421 increases. When we plot the standard deviation, we find that it is significantly higher in 422 the region that is most physiologically relevant, and that these differences can reach as 423 high as 10% ( Fig. 5) , making cellularity estimates based on vascular density difficult 424 and unreliable. Further, how the different patterns represented in these families of 425 simulations can affect the heterogeneity of oxygen within the domain, and the resultant 426 cellular-oxygen distributions, is unknown.
427
Effect on cellular-oxygen distribution in heterogeneous domains. To begin to 428 understand how the patterning of the vasculature affects the cellular-oxygen distribution 429 within our simulations, we consider two cases from the sample of our simulations for 430 two separate vessel densities (24 and 54 vessels). We plot and compare the vascular 431 patterns which support the maximum and minimum cellular populations from two given 432 vascular densities (Fig. 6) . We plot the minimum cellular population represented in the 433 left column at low (top) and high (bottom) relative vascular densities and the maximum 434 populations in the right column. 435 In both minimum population cases, there is a large peak of cells near to the hypoxic 436 minimum (c ap ) as well as a smaller peak around an oxygen concentration of 0.5. In the 437 maximum cellularity examples, however, these similarities disappear. In the low vessel 438 density, we see that the hypoxic population is maintained, but we have lost the central, 439 well oxygenated fraction, while in the high vessel density maximum population this is 440 reversed, and we lose the hypoxic population and the entire population is centered 441 to understanding radiation efficacy at larger scales, like TCP. How these effects are 456 governed by vessel organisation however, we have not yet elucidated. In this section 457 we will investigate the effects of differing vascular patterns on radiation efficacy.
458
Surviving cell number after radiation varies widely with vessel pattern. To 459 begin to understand the variability inherent in radiation effect, we calculate the number 460 of cells surviving after a single simulated dose of 2 Gy of radiation in each simulation 461 and plot the results as a function of vessel density (Fig. 7) . We previously found that as 462 the vessel density increases, the mean number of cells supported by the domain 463 increases in regular domains, and this holds in irregular domains as well ( Figure 10 ). All 464 else being equal, this should translate into an increase in the number of surviving cells 465 after radiation. We see that this relation holds for the low vessel density simulation 466 families, but as the vessel density increases above 0.01, the mean number of surviving 467 cells begins to decrease. Further, we observe, near this transition point, that the 468 standard deviation of surviving cells within each family of simulations peaks (Fig. 7,   469 inset). This highlights the fact that vessel density, and mean oxygen, are insufficient to 470 predict surviving cells, therefore, in order to better predict the number of surviving cells 471 in a domain, we require a measure of vascular organisation.
472
Standard deviation
Surviving Fraction
Vessel Density
Standard deviation
Surviving cells
Vessel density
Vessel density Vessel Density Figure 7 . Surviving cells versus vessel density for all simulations. We plot the number of surviving cells after 2Gy of simulated radiation in each simulation as calculated using equation (5) modified by the OER from equations (6) and (7) versus the number of vessels in each case for each of the 500 simulations with constant vessel number, but random placement, on domain size 73 × 73 at dynamic equilibrium. The edges of the boxes represent the 25th and 75th percentile, the whiskers extend to the most extreme data points not considered outliers. Outliers are defined as any simulation outside approximately 2.7 standard deviations, and they are plotted as red crosses. Inset we plot the standard deviation for each family of simulations versus the vessel number.
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Vessel density is insufficient to predict radiation effect. We have previously 473 shown that vascular density is a strong predictor for the carrying capacity of the tissue 474 in our model (Fig. 5 ). This is intuitive and, for regularly vascularized domains, as we 475 expect in healthy tissue, is sufficient to explain not only the carrying capacity, but also 476 other measures of the cellular distribution (e.g. the shape of the cellular-oxygen 477 distribution). We have now shown that this measure is not sufficient when we begin to 478 consider heterogeneously vascularized domains, as we know exist in cancer [64] , 479 where many possible spatial patterns can exhibit the same density. The mapping from 480 cellular-oxygen distribution to surviving cells is straightforward in the simulations we 481 have presented, as the cellular-oxygen distribution can be measured directly, and the 482 subsequent surviving cells can be calculated using equation (13) . In routinely obtained 483 tissue biopsy specimens however, it is not possible to measuring oxygen concentrations 484 at the cellular resolution. It would therefore be of translational value to define a metric 485 by which cellular-oxygen distribution, or the subsequent radiation efficacy, could be 486 inferred from a readily measurable surrogate, such as the distribution (and density) of 487 microvessels within these samples. The vascular normalisation hypothesis [65] suggests that radiotherapy should be more 491 efficacious when applied to tissues with normalised vascular beds. To test this in our 492 model, we introduce a spatial metric by which to understand the overall level of spatial 493 heterogeneity in our simulations. 494 We will utilise the variance stabilized Ripley's L function [21] to measure the 495 deviation from homogeneity in our vessel distributions. This measure, which is a 496 function of distance, describes the average number of points within a given distance of 497 any other point. For a complete description of this measure, see the supplemental 498 information.
499
Spatial metrics correlate directly with carrying capacity and with radiation 500 response if vessel density is known. In order to allow for easy correlation, we first 501 distill this metric (which is a function of distance) into a single number by taking the 502 mean value from 0 − 19 cell diameters (from adjacent to a distance beyond the ability to 503 affect one another). We calculate the mean Ripley's L function for all of the 500 504 simulations in each vessel number case and plot it against the associated carrying 505 capacity (Supplemental Fig. 10 ). We find a significant negative correlation for the lower 506 vessel densities which loses statistical significance (p-values not shown) as the 507 domains begin to reach confluence for all but the minority of vessel arrangements. 508 Fig. 8 shows scatter plots of Ripley's L function and surviving cells after radiation in 509 6 representative families of the 500 simulations with increasing vessel numbers. We 510 find that at low vessel densities there is a strong negative correlation between Ripley's L 511 function and surviving cells, but this correlation changes sign at high vessel densities, 512 explaining the counter-intuitive change in surviving fraction after Θ = 0.01 in Fig. 7 . This 513 suggests that in situations where the vessels are more rarefied, normalising existing 514 vasculature could actually make radiation less effective, in contrast to the vessel 515 normalisation hypothesis. Fig. 5 for a given initial vessel density between cell number surviving after 2 Gy of radiation (x-axis) and the mean of Ripley's L function (y -axis). We find that there is a positive correlation in the low vessel densities, and a negative correlation in the high vessel densities. All correlations are significant (p <<0.05), see Figure 11 .
Discussion
517
We have used an HCA model of vascular tumour growth in a planar domain to 518 investigate the dependence of cellular oxygenation and radiotherapy efficacy on 519 vascular density and patterning. Our results indicate that simple spatial summary 520 statistics such as Ripley's L function, which could be easily obtained from biopsy 521 images, may predict, together with more standard measures like vessel density, 522 radiation therapy efficacy and the effect of vascular normalisation on this. While our 523 model is parameterised from glioblastoma data, we anticipate these results to be more 524 widely applicable to other cancer types. 525 Our results corroborate those of Alarcón et al. [14] , who also used a HCA approach 526 to studying vascular tumour growth. However, our work differs in several key ways. tissue [17] , this time in a system utilizing en face oxygen sources, as in our work. We 538 have observed similar changes in cellular-oxygen distributions at equilibrium, and 539 indeed, it is these changes that drive our findings concerning radiation effect. 540 We have seen that the assumption that mean vessel density, and subsequently 541 mean oxygenation, can be used as a surrogate for the number of surviving cells after 542 radiation is insufficient. Further, we found that the relationship between each of our factor [18] , the world thought that the suggested method of blocking this factor, by 552 which it was promised that we could 'starve' tumours of their oxygen supply, would 553 dominate cancer research. It was thought that a cure for cancer would occur in a short 554 time period. However, early trials of single agent anti-angiogenic drugs failed to 555 produce results [20] . Later trials, with combinations of chemotherapy and 556 anti-angiogenic drugs, however, showed promise, but even this was discordant with the 557 leading hypothesis describing the mechanism of anti-angiogenic therapy, which was 558 thought to entirely starve tumours of blood supply. 559 It was not until 2001, when Jain suggested the 'vascular normalisation 560 hypothesis' [19] , that these results could be understood under a single rubric. Jain 561 suggested that anti-angiogenic drugs, instead of entirely blocking new vessel formation, 562 worked to normalise vasculature, pruning inefficient vessels and creating a more 563 regular lattice, thereby improving drug and oxygen delivery. More recent iterations of 564 this hypothesis also include improvement of the efficiency of existing vessels (reviewed 565 by Jain [65, 66] ). 566 While this advance in our thinking has provided a way to explain the counter-intuitive 567 results of many trials, it still does not explain why these combinations of anti-angiogenic 568 drugs with chemotherapeutics (or radiation therapy) do not help all patients. Using our 569 simple model system, we have observed a changing correlation with spatial measures 570 and radiation response. This suggests that in certain cases, 'improving' the 571 homogeneity of vascularisation would hurt the radiation effect, whilst in other cases it 572 would help: a heterogeneous response to 'normalisation' of vascular patterning. We 573 show that for certain cases, vessel density held constant, normal vascular patterning 574 can respond either better or worse to radiation therapy (Fig. 8) . 575 To translate these conclusions to the clinic would first require biological validation of 576 these hypotheses, as well as overcoming a number of model limitations. Specifically, 577 the assumption that all vessels are en face and all vessels are the same in terms of 578 size and efficiency. Validation could be achieved either through in vivo window chamber 579 experiments, or indirectly through examination of post-radiation surgical specimens. 580 Model development, to include the addition of angiogenesis, biologically derived vessel 581 geometries and vessel heterogeneity, could be used to extend these predictions to 582 more realistic situations. 583 
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If these limitations were addressed, and validation was achieved, the technology 584 exists currently to take advantage of this new idea. Specifically, macroscopic oxygen 585 concentrations could be inferred from DCE MRI (or other advanced imaging) to create 586 optimised dose plans, as suggested by Malinen et al. [7] . This information about 587 putative vessel density could then be coupled with histologic measurements using 588 automated localisation of vessels [26] and an algorithm to calculate Ripley's L. These 589 two pieces of information could then be incorporated by creating a temporally and a 590 spatially optimised radiation plan whereby the appropriate radiation dose would be 591 delivered before VNT to the area that would suffer after normalisation, and then the 592 final radiation could be delivered after VNT to the area that would benefit from it. sensitivity analysis of our model parameters, provide more detail on the spatial statistics 605 used in the paper and its correlation to carrying capacity and show the correlation and 606 p-values for the plots in Figure 8 .
607
Parameter estimation We assume that normal (brain) tissue has an approximate 608 oxygen concentration of 35mmHg [54] . This value also agrees well with an estimate of 609 background tissue oxygen concentration of c 0 = 1.7 × 10 −8 mol cm −2 (4.25 × 10 −13 610 mol cell −1 ) taken from Anderson and colleagues [47] after using the ideal gas law, 611 assuming body temperature of 310K, oxygen tension of 5300Pa [54] and cell volume of 612 125, 000µm 3 .
613
As each of these parameters has been estimated from different sources, we will fine 614 tune the basal oxygen consumption and physiologic vascular density for our specific 615 case using a well-studied tumour spheroid example. We utilize the observation that the 616 diffusion distance of oxygen to support cancer cells is approximately 10 cell 617 diameters [67] and the information from the literature concerning the ratio of cancer to 618 normal oxygen consumption. To estimate the baseline oxygen consumption rate then, 619 we begin with the value r c = 2.3 × 10 −16 mol cell −1 s −1 taken from an in vitro study of 620 tumour spheroid growth [51] and then perform a virtual tumour spheroid assay ( Fig. 9 ) 621 to fine tune the value for our model system.
622
Time scales and updates. The difference in time scales between the diffusion of 623 oxygen and the proliferation of cells is managed by updating the continuous part of the 624 model many times per cellular time step. This can become computationally expensive 625 in this explicit scheme, and therefore, we seek to minimize this number. However, for 626 Figure 9 . Tumour growth in an avascular domain with oxygen diffusion from the outside displays characteristics of tumour 'spheroid' growth. Here, an otherwise empty domain is initiated with a single cancer cell. The oxygen at the edge of the domain is set to c = 1. Cells (left) and oxygen concentration (right) are plotted at three time points: before the onset of central necrosis (top), initiation of central necrosis (middle) and later in progression (bottom) when a nearly constant sized proliferative 'rim' is observed. From this calibration, we find that the maximal oxygen uptake rate most appropriate for our model is r c = 7.5 × 10 −4 s −1 which correlated with an approximate 10 cell diameter thickness. stability, we require ∆tD c /∆x 2 < 0.25 [68] . We therefore choose ∆tD c /∆ 2 = 0.1. In 627 non-dimensional parameters, we then calculate 628 ∆t = 0.1(50 × 10 −4 cm) 2 1 × 10 −5 cm 2 s −1 = 0.25 s, (14) or equivalently in non-dimensional parameters 629 ∆t = 0.1(1 cell diameter) 2 23, 040 cell cycle −1 = 1 cell cycle 230, 400 ,
which equates to updating oxygen every 0.25 seconds, or approximately 230, 400 times 630 per cell cycle based on the parameters chosen (see Table 1 ). While we assume the 631 average cell cycle time to be τ = 16 hours, it is well known that cells in tissues are not 632 synchronized, and also that cell fate decisions such as apoptosis are made on shorter 633 time scales. To model this heterogeneity in cell cycle time and to more accurately 634 match the finer time scale associated with cell death due to microenvironmental 635 PLOS 22/30 cues [69] , we choose to update the cellular portion of our model 100 times per cell 636 cycle and scale the rates for cell behaviour accordingly (reduced by a factor of 100), 637 thereby reducing the oxygen calculations to 2, 304 updates per cellular update.
638
Sensitivity analysis To assay the model for sensitivity to parameters, we measure 639 the cellularity and cellular-oxygen distribution distributions for the regular vascularity 640 example reported in the center panel of Figure 2 , with Θ = 0.0027 (or a regular spacing 641 of 14 cell diameters). From the parameter set modeled in Figure 2 642 (D c = 0.1, r c = 1, K m = 0.01and c ap = 0.1) we vary each parameter by ≈ three orders of 643 magnitude and report the ranges for each mode of cellular oxygen distribution and 644 cellularity in Table 2 . 645 As expected, increasing cellular oxygen consumption (r c ) strongly influences the 646 ability for a given vascular architecture to support cells, with greater consumption 647 correlating with decreased cellularity. The mean oxygen experienced by cells goes 648 down and then up slightly as the number of cells decreases drastically. Variation in the 649 diffusion coefficient, D c , strongly affects the ability for a domain to support cells, and 650 also the mean and skewness of the resulting oxygen distribution, but affects the 651 standard deviation relatively little. Our choice of threshold for apoptosis, c ap , intuitively 652 has a strong effect on the cellularity, and then inversely on mean cellular oxygen as 653 fewer and fewer cells are competing for the same oxygen. The standard deviation is 654 affected little, and the skewness decreases at first and then increases as the number of 655 cells becomes smaller and smaller. 656 
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Spatial statistics To measure the variation away from homogeneity, we utilise a 657 measure derived from Ripley's K function. To begin, we have 658 K (r ) = λ −1 i =j
where λ is the average density of points in the domain, I is the indicator function which 659 yields 660 I(d ij < r ) = 1 if the Euclidian distance between vessels i and j is less than r , 0 otherwise.
We utilize the variance stabilized version of this measure,L(r ) which is given by 661 L(r ) =K (r ) π
which has an expected value ofL(r ) = 1 for homogeneous data. To correct for edge 662 effects, we implement the correction suggested by Ripley [21] , which changes the value 663 of the indicator function, for points assayed within r of the edge, to the reciprocal of the 664 proportion of the circle (of radius r ) which falls outside the study area. Fig. 5 for a given initial vessel density between cell number at equilibrium (x-axis) and Ripley's L (y -axis). We find that there is a significant negative correlation in the low vessel densities which loses predictive capability as the domain becomes entirely filled and all of the data points align at the full carrying capacity. PLOS 25/30
Figure 11. Correlation and p-value for Ripley's L function vs. surviving cells after radiation.
Here we plot the correlation coefficient (Left) vs. vessel density for all families of simulations and the corresponding p-value (Right). We notice that the correlation coefficient changes sign at 70 vessels, and the p-value briefly rises to insignificant (≈ 0.5) at the time of the sign change.
